As oncology nurses, we are uniquely positioned to proactively address the disparity in breast cancer mortality in the United States.
October is all about breast cancer awareness. The color pink is everywhere we look: pink ribbons, pink bracelets, and even pink hair. Yet with all of the awareness, African-American women are still dying at higher rates than their Caucasian counterparts.1
We as oncology nurses are uniquely positioned to be able to make a big impact in addressing this disparity in breast cancer mortality. Nurses can empower African-American women by:
References
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.